ObsEva Investors

55 investors on Angel Roster list ObsEva in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, the Netherlands and Germany.

Investors are matched on the company name in their portfolio, so companies that share the name ObsEva can appear together.

Investors listed
55
With verified email
51%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 40 ObsEva investors

The most complete profiles first. Showing 40 of 55.

  • Annie MitsakVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Bryan RobertsVerified

    Venture Capital, Entrepreneurship Program, Private Equity Firm · United States

    Series BSeries AAdvertisingHealth CareTelecommunicationsWomen Founded

    Portfolio: Nightfall AI, Biolux Research, Cloudflare, Adavium and 82 more

    Verified email available

  • Ed MathersVerified

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    Series BHealth CareE-commerceWomen FoundedEnterprise Software

    Portfolio: Rhythm Pharmaceuticals, Motus Therapeutics, Sentry, ObsEva and 15 more

    Verified email available

  • Ethan BatraskiVerified

    Venture Capital, Entrepreneurship Program, Private Equity Firm · United States

    Series BSeries AAdvertisingHealth CareRemote Work TechTelecommunications

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 66 more

    Verified email available

  • Harry BarberVerified

    Venture Capital, Investor · United States

    Series BSeries AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Nimish ShahVerified

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Noga YerushalmiVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Israel

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Owen LozmanVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Netherlands

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Sunny ReddyVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Todd GrahamVerified

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsCybersecurityWomen Founded

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Aftab KheraniVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alex RosenVerified

    Venture Capital · United States

    Health CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Andrew SchiffVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more

    Verified email available

  • AnneVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • David HickmanVerified

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Verified email available

  • Debbie BakerVerified

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Verified email available

  • Eric AguiarVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Javier RodriguezVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany

    Health CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Josh BilenkerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Josh FriedmanVerified

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Paulina HillVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Verified email available

  • Robert WenzelVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Ron HuntVerified

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Verified email available

  • Andrew Gottesdiener

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Cheryl Zimberlin

    Venture Capital, Corporate Venture Capital, Investor · Netherlands

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Christian Patze

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany

    SeedHealth CareDeepTechConsumer GoodsInfrastructure

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Francesco Draetta

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Katie Kerfoot

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Megan Blewett

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Michelle Doig

    Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Adam Soller

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Christopher Herr

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Contact details available

See all 55 ObsEva investors

Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.

Frequently asked questions

How many ObsEva investors are on Angel Roster?

Angel Roster lists 55 ObsEva investors. 28 of them (51%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (46), Private Equity Firms (27) and Corporate Venture Capital Firms (7). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do ObsEva investors invest in?

Among those that list a stage, the most common are Seed (14), Series A (6) and Series B (5).

Where are ObsEva investors based?

Most are based in the United States (46), the Netherlands (3) and Germany (3).

Which companies have ObsEva investors backed?

The most-backed portfolio companies among them are Versartis (23), Syros Pharmaceuticals (22), VelosBio (19), CVRx (18) and RefleXion Medical (18).

How do I contact ObsEva investors?

Create a free Angel Roster account to search and filter all 55, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.